Surface plasmon resonance imaging (SPRI) sensor for cystatin determination based on immobilized papain

Protein and Peptide Letters

Volumn 18, Issue 1, 2011, Pages 23-29

  Gorodkiewicz, E ^a   Luszczyn, J ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Biosensor; Blood plasma; Cystatin; Papain; Saliva; Surface plasmon resonance imaging; Urine

Indexed keywords

CYSTATIN; CYSTATIN C; CYSTATIN, EGG WHITE; CYSTATIN, EGG-WHITE; IMMOBILIZED ENZYME; PAPAIN;

ANIMAL; ARTICLE; BLOOD; CALIBRATION; CHEMISTRY; CHICK EMBRYO; HUMAN; INSTRUMENTATION; PH; SALIVA; SURFACE PLASMON RESONANCE; URINE;

ANIMALS; CALIBRATION; CHICK EMBRYO; CYSTATIN C; CYSTATINS; ENZYMES, IMMOBILIZED; HUMANS; HYDROGEN-ION CONCENTRATION; PAPAIN; SALIVA; SURFACE PLASMON RESONANCE;

EID: 78751523037     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611794328663     Document Type: Article

References (33)

1. Carvajal-Rondanelli, P. Diffusion of protease inhibitors in the muscle cell. PhD Thesis, Graduate Faculty of North Carolina State University, Department of Food Science, USA, 2002.
2. Abrahamson, M.; Alvarez-Fernandez, M.; Nathanson, C.J. Cystatins. Biochem. Soc. Symp., 2003, 70, 179-199.
3. Travis, J.; Potempa, J.; Maeda, H. Are bacterial proteinases pathogenic factors? Trends Microbiol., 1995, 3, 405-407.
4. Barrett, A.J. Cystatin, the egg white inhibitor of cysteine proteinases. Meth. Enzymol., 1981, 80, 771-778.
5. Rawlings, N.D.; Barrett, A.J. Evolution of proteins of the cystatin superfamily. J. Mol. Evol., 1990, 30, 60-71.
6. Grzonka, Z.; Jankowska, E.; Kasprzykowski, F.; Lankiewicz, L.; Wiczk, W.; Wieczerzak E.; Ciarkowski J.; Drabik P.; Janowski R.; Kozak M.; Jaskólski M. and Grubb A. Structural studies of cysteine proteases and their inhibitors. Act. Biol. Pol., 2001, 48, 1-20
7. Levy, E.; Lopez-Otin, C.; Ghiso, J.; Geltner, D.; Frangione B. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J. Exp. Med., 1989, 1, 1771-1778.
8. Jiborn, T.; Abrahamson, M.; Wallin, H.; Malm, J.; Lundwall, A.; Gadaleanu, V.; Abrahamsson, P.-A.; Bjartell, A. Cystatin C Is Highly Expressed in the Human Male Reproductive System. J. Androl., 2004, 25, 564-572.
9. Abrahamson, M.; Mason, R.W.; Hansson, H.; Buttle, D. J.; Grubb, A.; Ohlsson, K. Human cystatin C role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem. J., 1991, 273, 621-626.
10. Newman, D.J. Cystatin C. Ann. Clin. Biochem., 2002, 39, 89-104.
11. Baron, A.; Decarlo, A.; Featherstone, J. Functional aspects of the human salivary cystatins in the oral environment. Oral Dis., 1999, 5, 234-240.
12. Finney, H.; Newman, D.J.; Price, C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann. Clin. Biochem., 2000, 37, 49-59.
13. Simonsen, O.; Grubb, A.; Thysell, H. The blood serum concentration of cystatin C (g-trace) as a measure of the glomerular filtration rate. Scand J. Clin. Lab Invest., 1985, 45, 97-101. (Pubitemid 15106618)
14. Grubb, A.; Simonsen, O.; Sturfelt, G.; Truedsson, L.; Thysell, H. Serum concentration of cystatin C, factor D and b2-microglobulin as a measure of glomerular filtration rate. Acta Med. Scand., 1985, 218, 499-503. (Pubitemid 16147646)
15. Grubb, A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol., 1992, 38(Suppl), 20-7.
16. Siewiński, M.; Krçicki, T.; Rak, J.; Jarmulowicz, J. Thiol proteinase inhibitors in saliva of patients with laryngological cancer. Diagn. Oncol., 1992, 2, 141-144.
17. Konduri, S.D.; Yanamandra, N.; Siddique, K.; Joseph, A.; Dinh, D. H.; Olivero, W. C.; Gujrati, M.; Kouraklis, G.; Swaroop, A.; Kyritsis, A. P.; Rao, J. S. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene, 2002, 12, 8705-8712.
18. Mirtti, T.; Alanen, K.; Kallajoki, M.; Rinne, A.; Söderström, K-O. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. Prostate, 2003, 1, 290-298.
19. Yano, M.; Hirai, K.; Naito, Z.; Yokoyama, M.; Ishiwata, T.; Shiraki, Y.; Inokuchi, M.; Asano, G. Expression of cathepsin B and cystatin C in human breast cancer. Surg. Today 2001, 31, 385-389.
20. Finney, H.; Newman, D. J.; Gruber, W.; Merle, P.; Price, Ch. P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clinical Chemistry, 1997, 43, 1016-1022.
21. Newman, D.J.; Thakkar, H.; Edwards, R.G.; Wilkie, M.; White, T.; Grubb, A.; Price, C.P. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine, Kidney Int., 1995, 47, 312-318.
22. Kyhse-Andersen, J.; Schmidt, C.; Nordin, G.; Andersson, B.; Nilsson- Ehle, P.; Lindstrom, V.; Grubb, A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem., 1994, 40, 1921-1926.
23. Schipper, R.; Loof, A.; de Groot, J.; Harthoorn, L.; Dransfield, E.; Van Heerde, W. SELDI-TOF-MS of saliva: Methodology and pretreatment effects. J. Chromat. B., 2007, 847, 45-53.
24. Delanaye, P.; Cavalier, E.; Krzesinski, J.-M.; Mariat, Ch. Cystatin C-based equations: Don't repeat the same errors with analytical considerations. Nephrol Dial Transplant, 2008, 23, 1065-1076.
25. Lee, H.J.; Nedelkov D.; Corn, R.M. Surface plasmon resonance imaging measurements of antibody arrays for the multiplexed detection of low molecular weight protein biomarkers. Anal. Chem., 2006, 78(18), 6504-6510.
26. LaLonde, J.M.; Zhao, B.; Smith, W.W.; Janson, C.A.; DesJarlais, R.L.; Tomaszek, T.A.; Carr, T.J.; Thompson, S.K.; Oh, H.J.; Yamashita, D.S.; Veber, D.F.; Abdel-Meguid, S.S. Use of papain as a model for the structure-based design of cathepsin K inhibitors: Crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites. Med. Chem., 1998, 41, 4567-4576.
27. Gorodkiewicz, E. The Surface Plasmon Resonance Imaging Sensor for Papain Based on Immobilized Cystatin. Protein Pept. Lett., 2007, 14, 443-445.
28. Gorodkiewicz, E. Surface Plasmon Resonance Imaging sensor for cathepsin determination based on immobilized cystatin. Protein Pept. Lett., 2009, 16, 1379-1385.
29. Gorodkiewicz, E.; Fernández-González, A.; Akkoyun, A.; Steiner, G.; Salzer, R. Systematic evaluation of a surface plasmon resonance imaging biochip reader : Study of gold surface modifications. Chem. Anal. (Warsaw), 2005, 50, 103-116.
30. Machleidt, W.; Thiele, U.; Laber, B.; Assfalg-Machleidt, I.; Esterl, A.; Wiegand, G.; Kos, J.; Turk, V.; Bode, W. Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor. FEBS Lett., 1989, 243, 234-238.
31. Abrahamson, M.; Ritonja, A.; Brown, M.A.; Grubb, A.; Machleidt, W.; Barrett, A.J. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J. Biol. Chem., 1987, 262, 9688-9674.
32. Bjoerk, I.; Alriksson, E.; Ylinenjaervi, K. Kinetics of binding of chicken cystatin to papain. Biochemistry, 1989, 28, 1568-1573.
33. Cimerman, N.; Kosorok, M.D.; Korant, B.D.; Turk, B.; Turk, V. Characterization of cystatin C from bovine parotid glands: Cysteine proteinase inhibition and antiviral propertie. Biol. Chem. Hoppe Seyler, 1996, 377, 19-23.